<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166575">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02014298</url>
  </required_header>
  <id_info>
    <org_study_id>H3-2009-149</org_study_id>
    <nct_id>NCT02014298</nct_id>
  </id_info>
  <brief_title>Non Ablative Fractional Laser Treatment of Burn Scars</brief_title>
  <official_title>LONG-TERM AND CONTINUED IMPROVEMENT OF MATURE BURN SCARS IN RESPONSE TO NONABLATIVE FRACTIONAL LASER - A RANDOMIZED CONTROLLED TRIAL WITH HISTOLOGICAL EVALUATION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <authority>Denmark: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BACKGROUND: Increasing evidence appears for non-ablative fractional laser (NAFL) to remodel
      mature burn scars.

      OBJECTIVES: To investigate long-term clinical and histological appearance of mature burn
      scars after NAFL-treatment.

      HYPOTHESIS: That NAFL can modulate mature burn scars with subsequently improved cosmetic and
      functional appearance.

      METHODS: Study patients with burn scars at trunk or extremities. Side-by-side test areas are
      randomized to three monthly 1,540 nm NAFL-treatments or control, followed by blinded
      evaluations at 1, 3, and 6 months using mPOSAS (modified Patient and Observer Scar
      Assessment Scale; 1 = normal skin, 10 = worst imaginable scar).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in overall Scar-appearance</measure>
    <time_frame>1,3 and 6 months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary endpoint is change in overall scar-appearance assessed by a slightly modified Patient and Observer Scar Assessment Scale (evaluation of study area omitted since this is fixed as part of study procedure). Scale: 1= normal skin; 10= worst imaginable scar.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>specific clinical and histological scar appearance</measure>
    <time_frame>1, 3, and 6 months follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Additional assessments include:
evaluation of vascularity, pigmentation, thickness, relief, pliability (evaluated on modified Patient and Observer Scar Assessment Scale)
histological changes (Small safety issue from taking a 4 mm cutaneous punch biopsy)
patient satisfaction
adverse events (pain during treatment, immediate treatment reaction, 24h treatment reaction, evaluation of side effects at 6 months follow-up)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Burn Scars</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>One area assessed as a control area, compared to the laser-treated area</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ablative Laser treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 Non-ablative fractional laser treatments of one area</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>non-ablative fractional laser</intervention_name>
    <description>3 treatments with 4-6 weeks interval</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>non-ablative fractional er:glass laser</other_name>
    <other_name>1,540 nm laser treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>observation, comparison to laser-treated area</description>
    <arm_group_label>Non-ablative Laser treatment</arm_group_label>
    <other_name>observation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  legally competent adults aged 18-60 years

          -  Fitzpatrick skin type I-III

          -  burn scar 1 year or older

          -  total scar area allowing selection of two similar side-by-side test areas of minimum
             1.5 × 3 cm for study purpose

        Exclusion Criteria:

          -  pregnancy or lactation

          -  suntan

          -  wounds or infections in study area

          -  tendency to form hypertrophic scars or keloids

          -  oral retinoids, anti-inflammatory or immunosuppressive drugs within the last six
             months

          -  current anticoagulants

          -  previous treatments in test area with laser, Intense Pulsed Light, dermabrasion,
             chemical peel or filler.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete Hædersdal, MD,PhD,DmSc</last_name>
    <role>Study Director</role>
    <affiliation>Bispebjerg Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital, University of Copenhagen</name>
      <address>
        <city>Copenhagen NV</city>
        <state>Copenhagen</state>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 12, 2013</lastchanged_date>
  <firstreceived_date>December 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Elisabeth Taudorf</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Burns</keyword>
  <keyword>Non-ablative fractional laser</keyword>
  <keyword>scar texture</keyword>
  <keyword>histology</keyword>
  <keyword>laser treatment</keyword>
  <keyword>erbium:glass laser</keyword>
  <keyword>meshed skin-grafts</keyword>
  <keyword>photothermolysis</keyword>
  <keyword>skin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Burns</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
